Previous 10 | Next 10 |
KALY 1 st Six Months 2019 Revenue Is $165,000 Compared To $46,000 Last Year KALY Also Reported $70,000 Operating Net Income 1 st Six Months 2019 250% Revenue Growth Results From Q4 2018 Cannabis Business Acquired Q4 2018 KALY Owns And Operates Patented Cannabis Extraction Process And ...
DALLAS, Aug. 21, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company has filed a new patent application specifically on its formulation for symptoms associated with Chronic Obs...
DALLAS, Aug. 20, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed the company intends to publish up-to-date corporate financials on Thursday, August 22 nd . The company also plans ...
KALY Develops COPD Treatment CBD Formulation from Its Patented Extraction Process KALY Files New Patent Application on Its CBD Formulation for the Treatment of COPD KALY Files Trademark Registration on RespRx Brand Name for COPD Treatment Market for COPD Treatment Anticipated to Reach $...
DALLAS, Aug. 19, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled CEO update to be published tomorrow on Tuesday, August 20 th , 2019 to provide shareholders with the latest ...
DALLAS, Aug. 16, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today confirmed a scheduled CEO update to be published next week on Tuesday, August 20 th , 2019 to provide shareholders with the latest...
DALLAS, Aug. 15, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a scheduled CEO update to be published next week on Tuesday, August 20 th , 2019 to provide shareholders with the latest...
DALLAS, Aug. 13, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced the company anticipates a dramatic revenue increase in the second half of 2019 in conjunction with the hemp extraction c...
DALLAS, Aug. 06, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – Puration, Inc. (USOTC: PURA) (”PURA”) and Kali-Extracts (aka Kali, Inc.) (USOTC: KALY) (“KALY”) today confirmed adding CBD infused tea to its new line of CBD beverage partnerships. Last week...
DALLAS, Aug. 02, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (”PURA”) and Kali-Extracts (aka Kali, Inc.) (USOTC: KALY) (“KALY”) today published a management presentation to provide shareholders with more details on PURA’s...
News, Short Squeeze, Breakout and More Instantly...
Kali Inc Company Name:
KALY Stock Symbol:
OTCMKTS Market:
PAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership Highlights PR Newswire SANDUSKY, Ohio , May 6, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted that the upcoming CBD Nutraceutical Sales Rollout ...
Sandusky, Ohio--(Newsfile Corp. - May 5, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed a CBD Nutraceutical Sales Rollout Presentation scheduled this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under devel...
Sandusky, Ohio--(Newsfile Corp. - May 4, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today confirmed plans to present the Company's CBD Nutraceutical Sales Rollout Plan this Friday, May 7, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment ...